Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Cancer Reference Information
 
    All About This Topic
Other Information Sources
Glossary
Cancer Drug Guide
Treatment Options
Treatment Decision Tools
   
Detailed Guide: Neuroblastoma
What Are The Key Statistics About Neuroblastoma?

Neuroblastoma is by far the most common cancer in infants and the third most common type of cancer in children. There are approximately 650 new cases of neuroblastoma each year. This number has held steady for many years.

Boys are somewhat more likely to develop neuroblastomas than girls. For every 6 cases in male children, there are 5 in females.

The average age at the time of diagnosis is about 17 months. Around one-third of cases are diagnosed by the first year. Nearly 90% of cases are diagnosed by age 5. And about 2% of cases are found in people over the age of 10, including in some adults. In rare cases, neuroblastoma is detected by ultrasound even before birth.

In as many as 7 of 10 cases, the disease is not diagnosed until it has already spread (metastasized).

Revised 10-28-03

Printer-Friendly Page
Email this Page
Detailed Guide
What Is It?
Causes, Risk Factors and Prevention
Early Detection, Diagnosis, Staging
Treating Neuroblastoma
Talking With Your Doctor
More Information
Related Tools & Topics
Prevention & Early Detection  
Bookstore  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.